The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
DAB2 interactive protein (DAB2IP) methylation in serum DNA of non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations.
J. Wei
No relevant relationships to disclose
J. L. Ramirez
No relevant relationships to disclose
M. Taron
No relevant relationships to disclose
J. J. Sanchez
No relevant relationships to disclose
S. Benlloch
No relevant relationships to disclose
R. Rosell
No relevant relationships to disclose
M. Botia
No relevant relationships to disclose
M. Perez-Cano
No relevant relationships to disclose
P. Mendez
No relevant relationships to disclose
M. Tierno
No relevant relationships to disclose
C. Queralt
No relevant relationships to disclose
I. de Aguirre
No relevant relationships to disclose
B. Sanchez
No relevant relationships to disclose
A. Martinez
No relevant relationships to disclose
C. Buges
No relevant relationships to disclose
J. Bosch
No relevant relationships to disclose
B. Massuti
No relevant relationships to disclose
C. Camps
No relevant relationships to disclose
J. M. Sanchez
No relevant relationships to disclose
T. Moran
No relevant relationships to disclose